Skip to main content

Advertisement

SpringerLink
Log in

Collagen biomarker bioprofiles predicting the antifibrotic response to eplerenone in myocardial infarction: findings from the REMINDER trial

  • Letter to the Editors
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Khoury S, Carmon S, Margolis G, Keren G, Shacham Y (2017) Incidence and outcomes of early left ventricular thrombus following ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. Clin Res Cardiol 106(9):695–701

    Article  Google Scholar 

  2. Ferreira JP, Duarte K, Montalescot G, Pitt B, de Sa EL, Hamm CW, Flather M, Verheugt F, Shi H, Turgonyi E, Orri M, Rossignol P, Vincent J, Zannad F (2017) Effect of eplerenone on extracellular cardiac matrix biomarkers in patients with acute ST-elevation myocardial infarction without heart failure: insights from the randomized double-blind REMINDER Study. Clin Res Cardiol 107(1):49–59

    Article  Google Scholar 

  3. Zannad F, Alla F, Dousset B, Perez A, Pitt B (2000) Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investig Circ 102(22):2700–2706

    CAS  Google Scholar 

  4. Quilliot D, Alla F, Bohme P, Bruntz JF, Hammadi M, Dousset B, Ziegler O, Zannad F (2005) Myocardial collagen turnover in normotensive obese patients: relation to insulin resistance. Int J Obes (Lond) 29(11):1321–1328

    Article  CAS  Google Scholar 

  5. Iraqi W, Rossignol P, Angioi M, Fay R, Nuee J, Ketelslegers JM, Vincent J, Pitt B, Zannad F (2009) Extracellular cardiac matrix biomarkers in patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study. Circulation 119(18):2471–2479

    Article  CAS  Google Scholar 

  6. Montalescot G, Pitt B, Lopez de Sa E, Hamm CW, Flather M, Verheugt F, Shi H, Turgonyi E, Orri M, Vincent J, Zannad F (2014) Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the randomized double-blind reminder study. In: Eur Heart J, Published on behalf of the European Society of Cardiology The Author 2014. For permissions please email: journals.permissions@oup.com.: England, vol 35, pp 2295–2302

  7. Beygui F, Cayla G, Roule V, Roubille F, Delarche N, Silvain J, Van Belle E, Belle L, Galinier M, Motreff P, Cornillet L, Collet JP, Furber A, Goldstein P, Ecollan P, Legallois D, Lebon A, Rousseau H, Machecourt J, Zannad F, Vicaut E, Montalescot G (2016) Early Aldosterone blockade in acute myocardial infarction: the ALBATROSS randomized clinical trial. J Am Coll Cardiol 67(16):1917–1927

    Article  CAS  Google Scholar 

  8. Pitt B, Williams G, Remme W, Martinez F, Lopez-Sendon J, Zannad F, Neaton J, Roniker B, Hurley S, Burns D, Bittman R, Kleiman J (2001) The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study. Cardiovasc Drugs Ther 15(1):79–87

    Article  CAS  Google Scholar 

  9. Ferreira JP, Mentz RJ, Pizard A, Pitt B, Zannad F (2017) Tailoring mineralocorticoid receptor antagonist therapy in heart failure patients: are we moving towards a personalized approach? Eur J Heart Fail 19(8):974–986

    Article  CAS  Google Scholar 

  10. Lopez B, Gonzalez A, Ravassa S, Beaumont J, Moreno MU, San Jose G, Querejeta R, Diez J (2015) Circulating biomarkers of myocardial fibrosis: the need for a reappraisal. J Am Coll Cardiol 65(22):2449–2456

    Article  Google Scholar 

  11. Izawa H, Murohara T, Nagata K, Isobe S, Asano H, Amano T, Ichihara S, Kato T, Ohshima S, Murase Y, Iino S, Obata K, Noda A, Okumura K, Yokota M (2005) Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study. Circulation 112(19):2940–2945

    Article  CAS  Google Scholar 

  12. Klappacher G, Franzen P, Haab D, Mehrabi M, Binder M, Plesch K, Pacher R, Grimm M, Pribill I, Eichler HG et al (1995) Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis. Am J Cardiol 75(14):913–918

    Article  CAS  Google Scholar 

  13. Condorelli G, Jotti GS, Pagiatakis C (2016) Fibroblast senescence as a therapeutic target of myocardial fibrosis: beyond spironolactone? J Am Coll Cardiol 67(17):2029–2031

    Article  Google Scholar 

  14. Sun Y, Weber KT (2000) Infarct scar: a dynamic tissue. Cardiovasc Res 46(2):250–256

    Article  CAS  Google Scholar 

  15. Gyongyosi M, Winkler J, Ramos I, Do QT, Firat H, McDonald K, Gonzalez A, Thum T, Diez J, Jaisser F, Pizard A, Zannad F (2017) Myocardial fibrosis: biomedical research from bench to bedside. Eur J Heart Fail 19(2):177–191

    Article  Google Scholar 

  16. Ferreira JP, Machu JL, Girerd N, Jaisser F, Thum T, Butler J, Gonzalez A, Diez J, Heymans S, McDonald K, Gyongyosi M, Firat H, Rossignol P, Pizard A, Zannad F (2017) Rationale of the FIBROTARGETS study designed to identify novel biomarkers of myocardial fibrosis. ESC Heart Fail 5(1):139–148

    Article  Google Scholar 

  17. Heymans S, Gonzalez A, Pizard A, Papageorgiou AP, Lopez-Andres N, Jaisser F, Thum T, Zannad F, Diez J (2015) Searching for new mechanisms of myocardial fibrosis with diagnostic and/or therapeutic potential. Eur J Heart Fail 17(8):764–771

    Article  Google Scholar 

  18. Uusimaa P, Risteli J, Niemela M, Lumme J, Ikaheimo M, Jounela A, Peuhkurinen K (1997) Collagen scar formation after acute myocardial infarction: relationships to infarct size, left ventricular function, and coronary artery patency. Circulation 96(8):2565–2572

    Article  CAS  Google Scholar 

  19. Lopez B, Gonzalez A, Querejeta R, Larman M, Rabago G, Diez J (2014) Association of cardiotrophin-1 with myocardial fibrosis in hypertensive patients with heart failure. Hypertension 63(3):483–489

    Article  CAS  Google Scholar 

  20. Hayashi M, Tsutamoto T, Wada A, Tsutsui T, Ishii C, Ohno K, Fujii M, Taniguchi A, Hamatani T, Nozato Y, Kataoka K, Morigami N, Ohnishi M, Kinoshita M, Horie M (2003) Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction. Circulation 107(20):2559–2565

    Article  CAS  Google Scholar 

  21. Arantxa G, Schelbert EB, Diez J, Butler J (2018) Myocardial interstitial fibrosis in heart failure. J Am Coll Cardiol 71(15):1696–1706

    Article  Google Scholar 

  22. Lin YH, Chou CH, Wu XM, Chang YY, Hung CS, Chen YH, Tzeng YL, Wu VC, Ho YL, Hsieh FJ, Wu KD (2014) Aldosterone induced galectin-3 secretion in vitro and in vivo: from cells to humans. PLoS One 9(9):e95254

    Article  Google Scholar 

  23. Azibani F, Benard L, Schlossarek S, Merval R, Tournoux F, Fazal L, Polidano E, Launay JM, Carrier L, Chatziantoniou C, Samuel JL, Delcayre C (2012) Aldosterone inhibits antifibrotic factors in mouse hypertensive heart. Hypertension 59(6):1179–1187

    Article  CAS  Google Scholar 

  24. Lopez B, Gonzalez A, Querejeta R, Zubillaga E, Larman M, Diez J (2015) Galectin-3 and histological, molecular and biochemical aspects of myocardial fibrosis in heart failure of hypertensive origin. Eur J Heart Fail 17(4):385–392

    Article  CAS  Google Scholar 

  25. Sturgis LC, Cannon JG, Schreihofer DA, Brands MW (2009) The role of aldosterone in mediating the dependence of angiotensin hypertension on IL-6. Am J Physiol Regul Integr Comp Physiol 297(6):R1742–R1748

    Article  CAS  Google Scholar 

Download references

Author information

Author notes

  1. João Pedro Ferreira and António Barros contributed equally to this letter.

Authors and Affiliations

  1. Université de Lorraine, Inserm, Centre d’Investigations Cliniques-Plurithématique 14-33, and Inserm U1116, CHRU de Nancy, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France

    João Pedro Ferreira, Patrick Rossignol & Faiez Zannad

  2. Cardiovascular Research and Development Unit, Department of Physiology and Cardiothoracic Surgery, Faculty of Medicine, University of Porto, Porto, Portugal

    João Pedro Ferreira, António Barros & Adelino Leite-Moreira

  3. Division of Cardiology, University of Michigan School of Medicine, Ann Arbor, USA

    Bertram Pitt

  4. Institut de Cardiologie, Centre Hospitalier Pitié-Salpêtrière (AP-HP, ACTION Group, University Paris 6), 47 boulevard de l’Hôpital, 75013, Paris, France

    Gilles Montalescot

  5. Servicio de Cardiología, Hospital Universitario La Paz, Madrid, Spain

    Esteban Lopez de Sa

  6. Kerckhoff-Klinik, Heart Clinic, Bad Nauheim, Germany

    Christian W. Hamm

  7. Norwich Medical School, University of East Anglia, Norwich, UK

    Marcus Flather

  8. Onze Lieve Vrouwe Gasthuis (OLVG), Amsterdam, The Netherlands

    Freek Verheugt

  9. Pfizer Inc., New York, USA

    Harry Shi & John Vincent

Authors
  1. João Pedro Ferreira
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. António Barros
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bertram Pitt
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gilles Montalescot
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Esteban Lopez de Sa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Christian W. Hamm
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Marcus Flather
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Freek Verheugt
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Harry Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Adelino Leite-Moreira
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. John Vincent
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Patrick Rossignol
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Faiez Zannad
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Faiez Zannad.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 49 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ferreira, J.P., Barros, A., Pitt, B. et al. Collagen biomarker bioprofiles predicting the antifibrotic response to eplerenone in myocardial infarction: findings from the REMINDER trial. Clin Res Cardiol 107, 1192–1195 (2018). https://doi.org/10.1007/s00392-018-1373-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-018-1373-5

Search

Navigation